Your AI-Trained Oncology Knowledge Connection!

Morton Coleman, MD

home / authors / morton-coleman-md

Articles

December 15th 2013

While the name POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) provides a nice acronym for a collection of seemingly disparate features, the diagnosis does not require that all these elements be present, and many other features are not included.

Best Practices in the Management of Newly Diagnosed Multiple Myeloma Patients Who Will Not Undergo Transplant

Ruben Niesvizky, MD;Morton Coleman, MD;Tomer Mark, MD

March 16th 2010

No survival advantage of autologous stem cell transplantation (ASCT) has been documented for patients older than 65 years, and in the era of thalidomide (Thalomid), bortezomib (Velcade), and lenalidomide (Revlimid), ASCT has a diminished role in the front-line treatment of older patients with myeloma.

Management of Relapsed Mantle Cell Lymphoma: Still a Treatment Challenge

Jia Ruan, MD, PhD;Morton Coleman, MD;John P. Leonard, MD

July 15th 2009

Mantle cell lymphoma (MCL) is a distinct subtype of non-Hodgkin lymphoma that occurs most commonly in older patients with advanced-stage disease.